**Core Concept**
The Renin-Angiotensin-Aldosterone System (RAAS) is a vital physiological pathway that regulates blood pressure, fluid balance, and electrolyte homeostasis. It involves a cascade of enzyme-substrate interactions that ultimately lead to the production of aldosterone, a key hormone in blood pressure regulation.

**Why the Correct Answer is Right**
The RAAS mechanism is mainly regulated by the **Renin-Angiotensin Converting Enzyme (ACE) inhibitors**. Renin, released from the juxtaglomerular cells of the kidney, initiates the RAAS cascade by converting angiotensinogen to angiotensin I. ACE, present in the lungs, then converts angiotensin I to angiotensin II, a potent vasoconstrictor that stimulates the release of aldosterone from the adrenal cortex. This ultimately leads to increased blood pressure and fluid retention. The RAAS is also regulated by negative feedback mechanisms, including the stimulation of the baroreceptors in the aortic arch and carotid sinus by increased blood pressure, which inhibits the release of renin.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not specify a regulatory mechanism of the RAAS.
**Option B:** This option is incorrect as it refers to a different physiological pathway, the **Kallikrein-Kinin System**, which also regulates blood pressure but is not the main regulatory mechanism of the RAAS.
**Option C:** This option is incorrect as it refers to a **sympathetic nervous system** response, which can affect blood pressure but is not the main regulatory mechanism of the RAAS.

**Clinical Pearl / High-Yield Fact**
ACE inhibitors are commonly used to treat hypertension and heart failure by blocking the conversion of angiotensin I to angiotensin II, thereby reducing aldosterone levels and promoting vasodilation. They are also used to protect the kidneys from damage in patients with diabetes and chronic kidney disease.

**Correct Answer:** C.